Several participants who began the intervention from a chair were completing the exercise standing up by the end.
Notably, results were achieved without maintenance therapy.
There was a significant association between the average GCIP thickness and MSFC scores.
The new drug shows promise in the treatment of PPMS, for which there are currently no approved treatments.
The material of the device may play a significant role in the relationship.
Patients taking oral DMDs were more likely to experience relapse in the first year.
A comprehensive approach to managing depression may have far-reaching effects.
At follow-up, 22 patients were cognitively impaired compared to 34 at baseline.
Early screening is paramount to identifying patients at risk for suicide.
Neurology Advisor reviews the upcoming agenda for the CMSC annual meeting.
Neurology Advisor Articles
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Organic Solvents Plus Genetics May Increase Risk of Multiple Sclerosis
- No Significant Clinical Differences Between Cluster Headaches With and Without Aura
- Co-Prescription of Opioids and Antidepressants Prevalent in Migraine
- Deep Brain Stimulation May Slow Rest Tremor Progression in Parkinson Disease
- Herpesvirus Abundant in Alzheimer Disease Brain, New Study Finds
- Patients' Preferences for Physician Attire Linked to Perception of Care
- Weighing the Risks of Deep Brain Stimulation
- Grey Matter Atrophy Sequence in Multiple Sclerosis Phenotypes
- Higher Vitamin D Levels Associated With Fewer Lesions in Multiple Sclerosis
- Screening Tool Differentiates Progressive Supranuclear Palsy and Parkinson Disease
- Risk Factors for Impulse Control Behaviors in Parkinson Disease
- Cardiac Pathology in SUDEP Compared With Sudden Arrhythmic or Traumatic Deaths
- 11.2% of U.S. Adults Aged ≥45 Report Subjective Mental Decline
- AMA Aims to Boost Affordability of ACA Marketplace Plans